Abeona Therapeutics (ABEO) vs Cypherpunk Technologies (CYPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cypherpunk Technologies (CYPH) has outperformed Abeona Therapeutics (ABEO) over the past year, gaining 387.2% versus a loss of 3.2%. Over five years, ABEO leads with a -77.7% price change compared with -90.3% for CYPH. Abeona Therapeutics is the larger company by market cap ($284.8 million vs $280.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABEO | CYPH |
|---|---|---|
| Share price | $4.98 | $2.61 |
| Market cap | $284.78M | $280.73M |
| 1-day change | -1.97% | -14.62% |
| YTD return | -3.61% | +162.93% |
| 1-year return | -3.24% | +387.22% |
| 5-year return | -77.67% | -90.32% |
| P/E ratio (TTM) | — | 4.13 |
| EPS (TTM) | $-1.18 | $0.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.65 | $4.19 |
| 52-week low | $4.00 | $0.393 |
| Distance from 52-week high | -34.90% | -37.83% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +279.12% | +88.10% |
| Average volume | 1.41M | 9.88M |
| Shares outstanding | 57.18M | 107.76M |
| Employees | 226 | 6 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CYPH has outperformed ABEO by 390.5 percentage points over the past year.
About Abeona Therapeutics
ABEO stock →Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa.
Health Care · Biotechnology: Pharmaceutical Preparations · 226 employees
About Cypherpunk Technologies
CYPH stock →Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
ABEO vs CYPH FAQ
Which is bigger, Abeona Therapeutics or Cypherpunk Technologies?
Abeona Therapeutics (ABEO) is larger, with a market capitalization of $284.78M compared with $280.73M for Cypherpunk Technologies (CYPH).
Which stock has performed better over the past year, ABEO or CYPH?
CYPH returned +387.22% over the past 12 months, compared with -3.24% for ABEO (price return, excluding dividends). Past performance does not predict future results.
Are Abeona Therapeutics and Cypherpunk Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.